News for 'Viral Research'

BUSTED! 13 myths about hepatitis

BUSTED! 13 myths about hepatitis

Rediff.com28 Jul 2019

Hepatitis B virus is 10 times more infectious than hepatitis C virus and 50-100 times more infectious than HIV.

Monetary policy specialist Patra is new RBI dy guv

Monetary policy specialist Patra is new RBI dy guv

Rediff.com15 Jan 2020

Patra, as executive director of the central bank, was the principal advisor to the Monetary Policy Department since July 2012.

No data to show Delta plus impacts vaccine efficacy: Paul

No data to show Delta plus impacts vaccine efficacy: Paul

Rediff.com28 Jun 2021

It will be unfair to put a date for any COVID wave as the behaviour of coronavirus is unpredictable and a disciplined and effective pandemic response can help the country get away from any significant outbreak, COVID Task Force chief V K Paul said.

US withdraws emergency use of hydroxychloroquine for Covid-19

US withdraws emergency use of hydroxychloroquine for Covid-19

Rediff.com15 Jun 2020

The Food and Drug Administration said its decision is based on new information, including clinical trial data results, that have led it to conclude that the drugs may not be effective to treat COVID-19 and that its potential benefits for such use do not outweigh its known and potential risks.

CBSE textbook certifies 36-24-36 as best female body shape, sparks row

CBSE textbook certifies 36-24-36 as best female body shape, sparks row

Rediff.com12 Apr 2017

The incident comes against the backdrop of a raging debate on lack of scrutiny of the curriculum and content taught in schools.

Sensex, Nifty log best day in over 10 years; investors eye stimulus package

Sensex, Nifty log best day in over 10 years; investors eye stimulus package

Rediff.com25 Mar 2020

Reliance Industries was the top gainer in the Sensex pack, rallying up to 15 per cent, followed by Kotak Bank, Maruti, HDFC twins, Titan, L&T and Axis Bank. On the other hand, IndusInd Bank, ONGC, ITC and Bajaj Auto closed with losses. the NSE Nifty settled 516.80 points, or 6.62 per cent, up at 8,317.85.

Scientists identify ways of preventing next pandemic

Scientists identify ways of preventing next pandemic

Rediff.com4 Jan 2021

There can be no one answer to the question at the centre of an anxious debate across a world coping with COVID-19 and wondering what will happen if another one comes, but the global scientific community has been working on multiple tracks to ensure that humankind is better prepared.

Ola S1 scooters launched, prices start at Rs 99,999

Ola S1 scooters launched, prices start at Rs 99,999

Rediff.com16 Aug 2021

SoftBank-backed Ola Electric took the wraps off its maiden e-scooter offerings -- Ola S1 and S1 Pro -- for a commercial launch on Sunday. With prices starting from Rs 99,999 (excluding state government incentives, registration fee, and insurance cost), the Bhavesh Aggarwal-founded firm said the e-scooters are designed and engineered in India for the world and will deliver the best scooter experience to the consumer. He suggested that after 2025, sale of petrol-powered two-wheelers should not be allowed.

Coronavirus: What about the Lab in Wuhan?

Coronavirus: What about the Lab in Wuhan?

Rediff.com12 Apr 2020

Why did the Chinese military take over the lab in Wuhan in end January? Did something go wrong? Claude Arpi glances at the mystery surrounding the origin of the coronavirus.

India readies for massive testing exercise after lockdown

India readies for massive testing exercise after lockdown

Rediff.com28 Mar 2020

The ICMR is working on a war footing to develop the testing ecosystem -- especially for the screening blood tests. NIV, Pune, is in the process of validating antibody-based screening kits.

Covid-19 impact: Textile, paint makers roll out antiviral layer to ads

Covid-19 impact: Textile, paint makers roll out antiviral layer to ads

Rediff.com24 Nov 2020

Almost each of these companies has a different technology to show for the effectiveness against microbes.

Hydroxychloroquine can be fatal: Experts

Hydroxychloroquine can be fatal: Experts

Rediff.com6 May 2020

As the pandemic spreads and the urgency for effective treatment of COVID-19 mounts, several countries, including the US, have started relying heavily on HCQ, majorly used in the treatment of malaria and rheumatoid-arthritis.

'What Rahul Gandhi says today, PM Modi does tomorrow'

'What Rahul Gandhi says today, PM Modi does tomorrow'

Rediff.com22 Jun 2021

'We are only amplifying the voice of scientists and experts. We are gathering information by talking to experts and are sharing it. If the government chooses to ignore that, what can we do?'

Antiviral drug shows promise for treating COVID-19

Antiviral drug shows promise for treating COVID-19

Rediff.com30 Apr 2020

The White House described the development as "quite good news".

Alzheimer victims may thank Kiran Bhaskar soon

Alzheimer victims may thank Kiran Bhaskar soon

Rediff.com18 Jul 2019

Rediff.com Senior Contributor P Rajendran reports from New York on how the Indian-American researcher's pioneering work may wipe out the visible effect of Alzheimer's disease.

India again records over 78,000 new Covid-19 cases, tally crosses 37 lakh

India again records over 78,000 new Covid-19 cases, tally crosses 37 lakh

Rediff.com2 Sep 2020

The death toll climbed to 66,333 with 1,045 more fatalities reported in 24 hours.

Serum Institute ready to roll out Covid vaccine

Serum Institute ready to roll out Covid vaccine

Rediff.com3 Jan 2021

The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.

Sonia Gandhi to miss counting day as she flies abroad for medical check up

Sonia Gandhi to miss counting day as she flies abroad for medical check up

Rediff.com9 Mar 2017

Party sources said that she left for abroad on Wednesday night for a "routine medical check-up" and will return only after Holi on Monday.

COVID-19: 'We will be dealing with it for 2 years at least'

COVID-19: 'We will be dealing with it for 2 years at least'

Rediff.com29 Oct 2020

'The most intriguing thing (about COVID-19) is the range of the illness -- from asymptomatic or less symptoms to death and quite severe manifestations.' 'The vaccine will be at least another year away from having any effect.'

Can pvt labs do COVID-19 tests for free?

Can pvt labs do COVID-19 tests for free?

Rediff.com10 Apr 2020

'If the government doesn't subsidise, it would be a huge setback in the fight against COVID-19'

Antibodies may not guarantee protection from COVID-19: Scientists

Antibodies may not guarantee protection from COVID-19: Scientists

Rediff.com8 Sep 2020

As worries over India's COVID-19 spike mount -- the country added 75,809 cases on Tuesday to take its tally to 42,80,422 -- scientists are grappling with the pivotal issue of antibodies and trying to understand how they impact on the progression of the disease.

In a first, Twitter fact-checks Trump's tweets

In a first, Twitter fact-checks Trump's tweets

Rediff.com27 May 2020

Twitter highlighted 2 of Trump's tweets that falsely claimed mail-in ballots would lead to widespread voter fraud.

COVID: 'Treatment gets very challenging'

COVID: 'Treatment gets very challenging'

Rediff.com23 Jul 2021

'When you are on these drugs, there is a possibility that you come to the hospital late, just by virtue of the fact that you believe that things are going to turn around, because you are on all these medicines.'

How to solve financial sector's $75 bn problem

How to solve financial sector's $75 bn problem

Rediff.com28 Sep 2020

'The solution is to enable a graceful transfer of the deposit and funding 'franchise' from capital-deficient firms to capital-surplus firms.' 'This will expand credit intermediation, bring down its costs, and put the financial sector on a definite path of recovery,' argues former RBI deputy governor Viral Acharya.

23% Delhiites affected by COVID-19, finds sero-prevalence study

23% Delhiites affected by COVID-19, finds sero-prevalence study

Rediff.com22 Jul 2020

Director of the National Centre for Disease Control (NCDC) Dr Sujeet Kumar Singh said the remaining 77 per cent are still vulnerable to the viral disease and containment measures need to continue with the same rigour.

'COVID-19 can quietly enter your body, without causing pain'

'COVID-19 can quietly enter your body, without causing pain'

Rediff.com3 Dec 2020

'The COVID-19 virus has the power to quietly enter your body, without causing pain via symptoms, because it craftily manipulates your pain response.'

Thought her eco-crusade was bad idea: Greta Thunberg's dad

Thought her eco-crusade was bad idea: Greta Thunberg's dad

Rediff.com30 Dec 2019

Svante Thunberg revealed how his teen daughter, who initiated a global movement demanding world leaders take action over climate change, was crippled with depression and her activism has now made her 'very happy'.

COVID-19: 'There will be significant discoveries'

COVID-19: 'There will be significant discoveries'

Rediff.com9 Apr 2020

'Scientists around the world are focused on very quickly doing work to help us better understand what we are facing.' 'I am inspired by what scientists have found in such a short amount of time since the virus emerged.'

Data privacy: Tension between big technology firms and govt boils over

Data privacy: Tension between big technology firms and govt boils over

Rediff.com22 Mar 2021

There is a perception getting built inside the government that big technology companies -- a common term used for firms like Facebook, Google, Twitter, Amazon and the like - are becoming very powerful and present multiple threats to entire nations and their citizens today. The digital ecosystem is replete with CSAM (child sexual abuse material), fake news, drug trade, radicalisation, trolling among other social vices. Given the network effect that these platforms have, it is important to ensure that these platforms are not misused.

Drug to treat mild, moderate COVID-19 launched in India

Drug to treat mild, moderate COVID-19 launched in India

Rediff.com20 Jun 2020

FabiFlu is the first oral favipiravir-approved medication in India for the treatment of COVID-19. Favipiravir can be used for coronavirus patients with co-morbid conditions such as diabetes and heart disease with mild to moderate COVID-19 symptoms.

Tamiflu may do kids more more harm than good

Tamiflu may do kids more more harm than good

Rediff.com11 Aug 2009

Tamiflu, the anti-viral drug for swine flu, may do more harm than good to children afflicted with the H1N1 virus, a new study published on Monday says. The research published in the British Medical Journal says that antivirals Oseltamivir (Tamiflu) and Zanamivir (Relenza) are unlikely to prevent complications in childrenwho have swine flu.

When Nature Challenges A CM

When Nature Challenges A CM

Rediff.com6 Jan 2022

The chief minister still has time to repair the damage but he will have to act all-round, both at the government and party levels, suggests N Sathiya Moorthy.

'It is not easy to be a gatekeeper of financial stability'

'It is not easy to be a gatekeeper of financial stability'

Rediff.com19 Aug 2020

'There are deeper, underlying, forces at work and we need institutional arrangements to guard against them.'

US Fed cuts interest rate to almost zero

US Fed cuts interest rate to almost zero

Rediff.com16 Mar 2020

In a drastic measure to stem any major disruption to the US economy as a result of the coronavirus outbreak, the Federal Reserve has cut its benchmark interest rate to almost zero and said it would buy USD700 billion in bonds. The covid-19 pandemic has sickened more than 156,000 people worldwide and left more than 5,800 dead. The death toll in the US stands at 68, while infections neared 3,700.

How to keep your teeth healthy in the lockdown

How to keep your teeth healthy in the lockdown

Rediff.com20 Aug 2020

Brushing and flossing twice a day, rinsing your mouth after every meal will be a lot kinder to your mouth and wallet, advises Dr Aaditi Mahajan.

Mystery over the DRESS that broke the Internet solved

Mystery over the DRESS that broke the Internet solved

Rediff.com17 May 2015

MIT scientists have cracked the science behind the dress that went viral on the Internet after some saw it as black and blue while others perceived it to be gold and white.

Covishield: 'Single dose gives 71% effectiveness'

Covishield: 'Single dose gives 71% effectiveness'

Rediff.com20 Jul 2021

'You have sufficient protection if you take the second dose of the Covishield vaccine at 12 weeks, because this vaccine works in a way where it provides protection in the first dose.'

Should market experts be part of RBI's MPC?

Should market experts be part of RBI's MPC?

Rediff.com21 Aug 2020

'Three external members of the first MPC are respected researchers with excellent academic background, but there is no harm in considering academicians with diverse backgrounds such as finance and labour along with economists for this body,' recommends Tamal Bandyopadhyay.

Smoking increases your coronavirus risk

Smoking increases your coronavirus risk

Rediff.com30 May 2020

'Smokers are a highly susceptible population during this pandemic.' 'Health benefits from quitting smoking can start as early as within an hour.'

Must read: Facts you must know about first pregnancy

Must read: Facts you must know about first pregnancy

Rediff.com27 Jun 2019

It is important to visit an obstetrician as soon as you miss your first period after intercourse, suggests Dr Danny Laliwalla.